Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

ESMO GI 2020

Videos

CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC

Prof Bruno Sangro - University of Navarra, Pamplona, Spain
CheckMate 459: Long-term survival outcomes with nivolumab versus sorafenib as first-line treatment in aHCC ( Prof Bruno Sangro - University of Navarra, Pamplona, Spain )
15 Jul 2020

CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patients progressing on first-line chemotherapy

Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India
CAPIRI versus irinotecan for the treatment of advanced gall bladder cancer patients progressing on first-line chemotherapy ( Dr Anant Ramaswamy - Tata Memorial Hospital, Mumbai, India )
13 Jul 2020

DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer

Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan
DELIVER: Investigating the efficacy of nivolumab treatment in gastric cancer ( Prof Yu Sunakawa - St. Marianna University School of Medicine, Kawasaki, Japan )
13 Jul 2020

Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma

Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Phase I/II results: First-line NALIRIFOX in patients with pancreatic ductal adenocarcinoma ( Dr Zev Wainberg - Ronald Reagan UCLA Medical Center, Los Angeles, USA )
8 Jul 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation